GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Autonomix Medical Inc.
The shares of Autonomix Medical, a company developing a technology to treat nervous system disorders, are a venture capital bet. Their price will be determined by the results of clinical trials and the company's ability to demonstrate the effectiveness of its innovative approach.
Share prices of companies in the market segment - Specialized medical equipment
Autonomix Medical is a medical company developing technology for real-time detection and mapping of nerve signals during surgical procedures. We've categorized it as "Specialized Medical Equipment." The graph below shows the dynamics of the advanced surgical technology sector.
Broad Market Index - GURU.Markets
Autonomix Medical is a medical device company developing technology to detect and target nerves that cause certain diseases. Its innovative approach makes it a key component of the GURU.Markets index. The chart below represents the entire market. Find out how Autonomix compares to it.
Change in the price of a company, segment, and market as a whole per day
AMIX - Daily change in the company's share price Autonomix Medical Inc.
Autonomix Medical, Inc.'s daily stock price reflects volatility in the medical technology sector. This metric measures the stock's sensitivity to news regarding the development and approval of its microneurostimulation system.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that can be used to treat a variety of conditions. This is a cutting-edge medical equipment sector with high potential. The chart below shows the average volatility in this niche, allowing one to evaluate AMIX's performance against other innovative companies.
Daily change in the price of a broad market stock, index - GURU.Markets
Autonomix Medical develops technology for the diagnosis and treatment of diseases related to the nervous system. Shares of this innovative medical technology company are responding to clinical advances and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Autonomix Medical Inc.
Autonomix Medical, Inc.'s annual performance is a story of developing innovative technology for the treatment of pancreatitis and other conditions. Its 12-month market capitalization depends entirely on progress in clinical trials of its system, which uses denervation catheters. Success could offer a new approach to treating chronic pain.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Autonomix, an early-stage medical device company, is developing a nerve navigation technology. Its performance will depend entirely on the success of clinical trials and approval. Its stock price will reflect investors' speculative faith in its breakthrough technology.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Autonomix Medical develops technology for the diagnosis and treatment of peripheral nervous system diseases. Its annual market capitalization dynamics reflect investor expectations for the development of a new tool that could dramatically improve patients' quality of life. This is a story of how one innovation can create a new market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Autonomix Medical Inc.
Autonomix is a medical device company developing technology for the nervous system. Being in the early stages, its monthly valuation is based on expectations. News about technological milestones, prototype testing, and progress toward FDA approval are the main drivers.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Autonomix Medical is developing micro-neurostimulation technology that can be used to diagnose and treat various diseases. The company is in the early stages of development. The medical device sector's performance reflects a general interest in innovation, providing a backdrop for assessing the breakthrough, yet high-risk, potential of Autonomix's technology.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Autonomix Medical develops technology for navigating catheters within the nervous system. This is a cutting-edge field in medical device engineering. The company's stock price is completely uncorrelated with the market, but rather reflects the progress of its development and investors' faith in the potential of its unique technology.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Autonomix Medical Inc.
Autonomix Medical is developing a technology for navigating catheters within the nervous system, opening up new treatment options. Its weekly stock price, like that of any medical tech startup, is a response to news about clinical trials, patents, and investor confidence in the breakthrough potential of its platform.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Autonomix Medical is developing technology for navigating catheters within the nervous system, which could improve chronic pain treatment. This is a disruptive but risky field. This chart allows you to gauge how investors are reacting to the company's news compared to the overall sentiment in the medical device sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Autonomix Medical is developing a technology for treating chronic pain. This is a breakthrough, but risky, area of medicine. The chart will show how its shares navigate their own news cycle, reacting to regulatory approvals, separate from overall market movements.
Market capitalization of the company, segment and market as a whole
AMIX - Market capitalization of the company Autonomix Medical Inc.
Autonomix Medical's market capitalization reflects investors' bets on its technology for treating diseases related to the nervous system. The chart shows the market's confidence in its microsensors, which could be used for targeted therapy. Its value reflects the potential of its early, preclinical developments.
AMIX - Share of the company's market capitalization Autonomix Medical Inc. within the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology. The company's market share in the medical equipment sector is negligible, reflecting its early stage. Its market cap reflects investors' bet on its innovative platform, which could enable ultra-precise manipulation of nerve endings.
Market capitalization of the market segment - Specialized medical equipment
This graph shows the total value of the entire specialized medical equipment market. For Autonomix Medical, which develops microneurosurgery technology, this line is a map of the future. The graph's growth reflects how technology enables increasingly precise and minimally invasive interventions, which is the company's goal.
Market capitalization of all companies included in a broad market index - GURU.Markets
Autonomix Medical develops technology for navigating catheters within the body using nerve signals. Its market capitalization is based on its innovative approach to minimally invasive surgery. This represents the market share of "GPS for the nervous system."
Book value capitalization of the company, segment and market as a whole
AMIX - Book value capitalization of the company Autonomix Medical Inc.
Autonomix Medical develops technology for navigating catheters inside the human body. Its book value is its scientific and technological capital: patents, R&D equipment, and research funds. How has this innovative medical capital changed? The chart below shows.
AMIX - Share of the company's book capitalization Autonomix Medical Inc. within the market segment - Specialized medical equipment
Autonomix Medical, Inc. develops technology for microneurosurgery. Its innovations require a physical base: R&D labs for creating its navigation systems and prototype workshops. The chart shows its share of the physical infrastructure required for the development of advanced surgical instruments.
Market segment balance sheet capitalization - Specialized medical equipment
Autonomix Medical is a medical technology company. This sector, as the chart shows, is capital-intensive. Autonomix is developing a unique device, and its capital is invested in the R&D and production of this complex product.
Book value of all companies included in the broad market index - GURU.Markets
Autonomix Medical's assets are not factories, but a team of engineers and laboratories developing microneurosurgery technology that enables the detection and mapping of nerves during surgery. Its book value reflects its research-intensive potential in this niche but important field of medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Autonomix Medical Inc.
Autonomix Medical is a medical technology company developing a system for detecting and mapping nerves during surgical procedures. Its market value is based on its potential to improve surgical safety and precision.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Autonomix Medical is developing a technology for navigating catheters inside the body. This is an innovation in minimally invasive surgery. The chart shows how investors view this technology and its potential to make complex procedures safer and more precise, a key trend in medicine.
Market to book capitalization ratio for the market as a whole
Autonomix Medical develops technology for navigating medical instruments within the nervous system. The company's value is determined by the uniqueness and potential of its developments. This chart demonstrates the premium the market is willing to pay for advanced medical technologies that could radically change approaches to surgery.
Debts of the company, segment and market as a whole
AMIX - Company debts Autonomix Medical Inc.
Autonomix Medical develops technology for navigation in the peripheral nervous system. As an early-stage medical device company, it relies entirely on venture capital and equity to fund R&D and preclinical trials. This chart reflects the initial, most capital-intensive stage of its development.
Market segment debts - Specialized medical equipment
Autonomix Medical is a medical technology company developing a system for detecting and mapping nerve signals. This technology could have applications in the treatment of chronic pain and other neurological conditions. The chart shows how the early-stage company is funding its R&D and preparing for clinical trials of its innovative platform.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Autonomix Medical Inc.
Autonomix Medical is developing technology for real-time navigation of catheters within the human body, which could improve a range of surgical procedures. The development and clinical trials of such complex medical equipment require significant investment. This chart shows how the company uses debt to finance its innovative, yet capital-intensive, developments.
Market segment debt to market segment book capitalization - Specialized medical equipment
Autonomix Medical is developing a technology for navigating catheters inside the human body, which could be used in neurology. This is cutting-edge medical technology. This chart shows how the company finances its R&D. It compares its debt load to the market capitalization of the entire medical device sector, reflecting its financial risks.
Debt to book value of all companies in the market
Autonomix Medical develops technology for navigation and nerve probing during surgical procedures. Medical innovations require significant and long-term capital investment. Does the company use debt for its R&D? This chart, reflecting the overall debt burden in the economy, provides context for assessing its financial stability.
P/E of the company, segment and market as a whole
P/E - Autonomix Medical Inc.
Autonomix Medical is a medical technology company developing technology for detecting and mapping abnormal neural signals. This chart, released after its IPO, shows how investors assess the potential of its diagnostic platform. The valuation depends on success in research and clinical applications.
P/E of the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that enables precise targeting of nerve signals. The company focuses on the treatment of chronic pain and other neurological disorders. This chart illustrates the average rating in the specialized medical equipment sector, which values breakthrough technologies for minimally invasive surgery.
P/E of the market as a whole
Autonomix Medical, Inc. develops microneurostimulation technology that can be used to diagnose and treat diseases related to the nervous system. This chart reflects the overall sentiment in the medical technology sector. It helps us understand whether AMIX's high valuation is the result of faith in its unique technology or is part of general industry optimism.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Autonomix Medical Inc.
Autonomix Medical is developing microneurostimulation technology that can be used to treat various nervous system disorders. The company's future depends on the success of its clinical programs. This chart reflects the investors' confidence in the potential of this innovative therapeutic platform and its ability to address complex medical problems.
%20P%2FE%20Autonomix%20Medical%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Autonomix-Medical-Inc.&v=1772513537661 "Chart of the company's future (projected) P/E Autonomix Medical Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that can be used to treat a variety of chronic diseases. This is a cutting-edge and complex medical sector. The chart reflects future profit forecasts for the industry, helping to understand how much investors believe in the breakthrough potential and commercialization of this technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772513537675 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Autonomix Medical is developing microneurosurgery technology that can be used to diagnose and treat neurological diseases. This is a cutting-edge medical development. This market sentiment chart shows how willing investors are to fund companies creating revolutionary surgical tools.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513537684 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Autonomix Medical Inc.
Autonomix Medical, Inc. is a medical device company in development, designed to address problems related to the nervous system. The financial metrics in this chart likely reflect investments in research, engineering, and preparation for clinical trials, which is typical for companies at this stage.
Profit of companies in the market segment - Specialized medical equipment
Autonomix Medical, Inc. is a medical technology company developing a system for detecting and mapping nerve signals, which can be used to diagnose and treat neurological disorders. This chart shows the overall profitability of the specialized medical equipment sector, where innovative diagnostic tools can revolutionize treatment approaches.
Overall market profit
Autonomix Medical, Inc. develops technology for detecting and mapping nerve signals. The company is an early-stage company in the medical technology sector. Its value and prospects are determined by the potential of its innovations and future research, rather than by the current economic environment, as illustrated by this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Autonomix Medical Inc.
Autonomix Medical is developing technology for navigation and nerve probing during surgical procedures. Future revenue depends on the commercialization of this technology and its acceptance by surgeons. This chart reflects analyst expectations regarding demand for solutions that improve precision and safety in microsurgery.
%20profit%20of%20the%20company%20Autonomix%20Medical%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Autonomix-Medical-Inc.&v=1772513537767 "Graph of future (projected) profit of the company Autonomix Medical Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that can be used to diagnose and treat neurological disorders. The company's goal is to create more precise and less invasive treatments. This graph shows revenue expectations for the specialized medical equipment sector, helping to assess the potential of Autonomix's technology.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772513537769 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Autonomix Medical, Inc. develops technology for detecting and mapping nerve signals. It is an early-stage company, dependent on funding to complete development. This earnings forecast chart reflects overall investor sentiment and their willingness to invest in high-risk but potentially breakthrough medical technologies.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513537777 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Autonomix Medical Inc.
Autonomix Medical develops a technology for microneurosurgery. Being in the development and clinical trials phase, the company may not have stable revenue. This chart reflects investor sentiment regarding its innovative approach and potential to transform existing surgical practices.
P/S market segment - Specialized medical equipment
Autonomix Medical is developing microneurosurgery technology that can be used to treat a wide range of chronic diseases by manipulating nerve signals. This innovative approach opens new horizons in medicine. This chart shows the average revenue estimate for the sector, helping to understand market expectations for this breakthrough medical technology.
P/S of the market as a whole
Autonomix Medical is developing microneurostimulation technology that can be used to diagnose and treat various diseases. This chart highlights that the valuation of companies developing breakthrough medical platforms is based on the expected future applications of their technologies, not on current revenue.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Autonomix Medical Inc.
Autonomix Medical develops microneurosurgery technology that can be used to treat various diseases by manipulating nerve signals. For a company with such innovative medical technology, future revenue valuation is key. It reflects investors' confidence in the potential of this platform to create new treatments and its future commercial success.
%20P%2FS%20Autonomix%20Medical%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Autonomix-Medical-Inc.&v=1772513537868 "The graph of the company's future (projected) P/S Autonomix Medical Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that can be used to diagnose and treat peripheral nervous system disorders. This chart compares the company's estimated future sales with expectations for the medical device sector. It shows how investors view the potential of its innovative platform for developing new treatments.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772513537905 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Autonomix Medical is developing microneurosurgery technology that can be used to treat a wide range of conditions by manipulating nerve signals. The company's future depends on the commercialization of this platform. This chart of overall market expectations reflects investor confidence that bioelectronic medicine will become a new direction in healthcare.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513537936 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Autonomix Medical Inc.
This figure reflects the financial activity of Autonomix Medical, a company developing technology for the diagnosis and treatment of diseases related to the peripheral nervous system. Being in an early stage, the company may not have sales revenue. The figures reflect its R&D activities.
Sales of companies in the market segment - Specialized medical equipment
Autonomix Medical is developing a microneurosurgery technology that can be used to treat a variety of conditions. Being in the development stage, the company is currently revenue-neurosurgical. Its future revenue will depend on the successful commercialization of its innovative platform, which is aimed at high-precision medical interventions.
Overall market sales
Autonomix Medical, Inc. develops technology for navigation and probing during minimally invasive surgical procedures. The company strives to improve surgical precision and safety. This overall economic activity impacts hospital budgets, but the primary driver for Autonomix is the need for more advanced medical technology.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Autonomix Medical Inc.
Autonomix Medical is a medical technology company developing a microneurosurgery system that can be used to diagnose and treat peripheral nervous system disorders. Future revenue depends on the commercialization of this technology. This chart reflects analyst expectations for hospital and surgeon demand for its innovative platform.
%20sales%20of%20the%20company%20Autonomix%20Medical%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Autonomix-Medical-Inc.&v=1772513538026 "Schedule of future (projected) sales of the company Autonomix Medical Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Autonomix Medical is developing microneurosurgery technology aimed at treating nervous system disorders. This chart illustrates the forecast for the medical equipment market. Is demand for minimally invasive and high-precision surgical technologies growing? This reflects the overall trend in medical equipment development.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772513538043 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Autonomix Medical is a company developing medical devices, likely for neurological applications. Demand for innovative medical equipment depends on its clinical effectiveness, insurance coverage, and healthcare facility budgets. While the overall economic climate impacts these budgets, breakthrough technology can create demand in any economic environment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513538093 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Autonomix Medical Inc.
Autonomix Medical is developing technology for navigation and nerve probing during medical procedures. This chart reflects the company's financial performance during the development phase. Profitability is a future goal and will depend on the successful development and commercialization of its innovative platform, which can improve the precision and safety of surgical interventions.
Market segment marginality - Specialized medical equipment
Autonomix Medical, Inc. is a medical technology company developing a system for detecting and mapping nerve signals in the body. While in the development stage, the company incurs significant R&D expenses. This chart shows its current financial metrics, with profitability being a long-term goal dependent on the successful commercialization of its innovative technology.
Market marginality as a whole
Autonomix Medical is developing technology for navigating medical instruments inside the body, likely for minimally invasive procedures. Its success depends on surgeons' acceptance of the technology. This overall profitability chart reflects the state of the healthcare system and its ability to invest in advanced equipment to improve treatment outcomes.
Employees in the company, segment and market as a whole
Number of employees in the company Autonomix Medical Inc.
Autonomix Medical develops microneurosurgery technology. Given its early stage, the team is small and consists of engineers and scientists. This chart shows how the medical device startup is expanding its staff to complete product development and navigate complex regulatory processes before entering the market.
Share of the company's employees Autonomix Medical Inc. within the market segment - Specialized medical equipment
Autonomix Medical develops microneurosurgery technology that can be used to treat a variety of conditions. Creating such innovative medical devices requires a team of engineers, scientists, and clinicians. This graph shows the company's market share, reflecting its scientific potential and stage of development toward commercialization.
Number of employees in the market segment - Specialized medical equipment
Autonomix Medical develops technology for nerve navigation and ablation, which can be used to treat a variety of chronic conditions, including pain and hypertension. The chart reflects employment in the specialized medical equipment sector. Autonomix's minimally invasive procedures may offer new hope to patients with difficult-to-treat conditions.
Number of employees in the market as a whole
Autonomix Medical develops technology for the diagnosis and treatment of diseases related to the peripheral nervous system. This is a breakthrough field at the intersection of microneurosurgery and robotics. This graph shows overall employment, while Autonomix illustrates how the convergence of technologies is creating entirely new medical specialties and jobs of the future.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Autonomix Medical Inc. (AMIX)
Autonomix Medical is a medical technology company developing a platform for detecting and treating neurological disorders. This is high-tech R&D. This chart shows the high market value the market attributes to their innovative technology. It reflects the value of their intellectual capital per engineer.
%20of%20the%20company%20Autonomix%20Medical%20Inc.%20(AMIX)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Autonomix-Medical-Inc.-AMIX&v=1772513538290 "Chart of market capitalization per employee (in thousands of dollars) of the company Autonomix Medical Inc. (AMIX)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Autonomix Medical (AMIX) is developing microneurosurgery technology aimed at diagnosing and treating peripheral nervous system disorders. In the field of advanced medical technology, this metric reflects revolutionary potential. The high market capitalization per employee suggests that their technology could revolutionize approaches to chronic pain treatment.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772513538350 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Autonomix Medical develops technology for microneurosurgery. In the medical device sector, this indicator reflects the value of innovation. The market appreciates the potential of its unique technology for high-precision procedures, which could significantly improve treatment outcomes and create a new standard in surgery, hence the engineer's high rating.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513538358 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Autonomix Medical Inc. (AMIX)
Autonomix Medical is a company developing a technology (catheter) for targeted therapy of neurological diseases (such as chronic pain). It is an R&D company in the medical device industry. This chart shows the company's current stage. The loss per employee indicates that engineers and doctors are still in the development and clinical trials phase.
%20Chart%20Autonomix%20Medical%20Inc.%20(AMIX)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Autonomix-Medical-Inc.-AMIX&v=1772513538367 "Company Profit Per Employee (in thousands of dollars) Chart Autonomix Medical Inc. (AMIX)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Autonomix Medical, Inc. develops technology for the diagnosis and treatment of peripheral nervous system disorders. In the field of advanced medical equipment, employee productivity is an indicator of the value of intellectual property. This graph illustrates how investing in a small team of highly skilled engineers and scientists can lead to the creation of a breakthrough product.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772513538397 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Autonomix Medical is an early-stage medtech company developing a technology for detecting and treating neurological disorders, such as chronic pain. This is a knowledge-intensive R&D company. This chart, showing average market efficiency, helps to understand the contrast with the R&D business, where capital is invested in research per scientist.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513538460 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Autonomix Medical Inc. (AMIX)
Autonomix Medical is developing a technology for navigating medical instruments within the nervous system. For a MedTech startup, this graph shows the path to commercialization. Increasing revenue per employee will signify successful approval and implementation of their technology in clinical practice, monetizing their unique developments.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Autonomix-Medical-Inc.-AMIX&v=1772513538489 "Sales chart per company employee Autonomix Medical Inc. (AMIX)")
Sales per employee in the market segment - Specialized medical equipment
Autonomix Medical is a clinical-stage biotech/medtech company. They are developing a technology (microcatheter) for the detection and treatment of nerve disorders, including pancreatitis. They have no commercial revenue. This chart, showing the average revenue in the sector, serves as a benchmark for AMIX's R&D staffing costs.
Sales per employee for the market as a whole
Autonomix Medical is a medical technology company developing a platform for detecting and treating neurological disorders. Currently, their focus is on R&D and clinical trials. This graph reflects their pre-commercial phase, when the entire team of engineers and doctors is dedicated to developing the technology.
Short shares by company, segment and market as a whole
Shares shorted by company Autonomix Medical Inc. (AMIX)
Autonomix Medical (AMIX) is an early-stage company developing technology to treat diseases using microelectric impulses. This chart tracks short positions. Shorting here is a bet that the company's technology is too immature, risky, and lacks a clear path to commercialization.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Autonomix-Medical-Inc.-AMIX&v=1772513538592 "Short Shares Chart for the Company Autonomix Medical Inc. (AMIX)")
Shares shorted by market segment - Specialized medical equipment
Autonomix Medical (AMIX) is a company developing technology to detect and map nerve signals in the heart, which should aid in the treatment of arrhythmia. This chart shows the overall short position in the medical devices sector, highlighting investor concerns about competition or a slowdown in the adoption of new technologies.
Shares shorted by the overall market
Autonomix (AMIX) is an R&D company developing medical devices. It's a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks, like AMIX, whose fate depends on R&D and regulatory approval.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Autonomix Medical Inc. (AMIX)
Autonomix Medical (AMIX) develops microneurostimulation technology that can be used to treat various conditions, including pancreatitis. It's cutting-edge medical technology. This chart measures price momentum. It helps identify when the stock is "overheated" (above 70) on the FDA news or "oversold" (below 30) due to profit-taking.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Autonomix-Medical-Inc.-AMIX&v=1772513538711 "RSI 14 indicator chart for the company's stock Autonomix Medical Inc. (AMIX)")
RSI 14 Market Segment - Specialized medical equipment
Autonomix Medical (AMIX) is a medical technology company developing a catheter-based system for detecting and mapping nerve signals in the heart. This could aid in the treatment of arrhythmia. This chart tracks the collective sentiment in the specialized medical equipment sector, helping to assess how investors view this unique niche in cardiology.
RSI 14 for the overall market
Autonomix Medical (AMIX) is a biotech company. Like everything in its sector, it's critically dependent on this chart. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AMIX (Autonomix Medical Inc.)
Autonomix Medical is an early-stage medical device company developing technology (a microcatheter with sensors) for high-precision mapping of the peripheral nervous system. This chart shows the highly speculative average price target from analysts, based on their belief in the potential of this diagnostic and therapeutic R&D platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AMIX-Autonomix-Medical-Inc.&v=1772513538760 "A chart showing analyst consensus forecasts for the expected stock price. AMIX (Autonomix Medical Inc.)")
The difference between the consensus estimate and the actual stock price AMIX (Autonomix Medical Inc.)
Autonomix is a medical technology company developing a technological platform (microcatheters) for mapping and treating peripheral nerves, including chronic pain. This chart shows the upside and downside potential of the stock according to analysts. It measures the gap between the price and forecast, reflecting their faith in this innovative technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AMIX-Autonomix-Medical-Inc.&v=1772513538773 "A chart showing the difference between the consensus forecast and the actual stock price. AMIX (Autonomix Medical Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Autonomix Medical (AMIX) is a biotech company developing micro-neurostimulation technology for the diagnosis and treatment of peripheral nervous system disorders. This chart shows general expectations for the specialized medical equipment sector, reflecting experts' confidence in this sophisticated R&D platform.
Analysts' consensus forecast for the overall market share price
Autonomix Medical is a medical company developing technology (microcatheters) for "reading" and stimulating nerves, specifically for the treatment of pain and pancreatitis. This chart shows the overall "risk appetite" in the market. For Autonomix, a company with an innovative but not yet commercialized technology, overall market optimism (risk appetite) is critical for R&D funding.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Autonomix Medical Inc.
Autonomix Medical is an R&D company working at the intersection of nerves and robotics. Their signature product is a microcatheter (navigated by AI) designed to visualize and treat (ablate) nerves that cause chronic pain. This chart is purely an indicator of their R&D. It doesn't reflect revenue, but rather a speculative estimate of their (very risky) pipeline and their chances of FDA approval.
AKIMA Market Segment Index - Specialized medical equipment
Autonomix Medical (AMIX) is developing a high-tech neuromodulation platform. Their system senses peripheral nerve signals and then treats them (for example, for chronic pain) using catheter technology. This chart shows the average index for the segment, helping investors assess how this neural technology compares to the average.
The AKIM Index for the overall market
Autonomix Medical is a medtech company developing catheter technology for detecting and ablating nerve signals (for pain and cancer treatment). This chart, reflecting the market average, provides context. It helps assess how this early-stage innovation stacks up against overall macroeconomic trends.
